Genus plc

Biotechnology
GNS.L
GBX 2,012 (2)%
Share price
$ 1.9 bn
Market Cap
$ 1.9 bn
Enterprise Value

Carbon footprint

42 Ton
GHG emissions per $ 1 mln investment
1.2x the weighted average for S&P 500
FY2021
How is this calculated?
-6.4%
YOY change in GHG emissions
Weaker than the +0.5% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

-3.4%
Proj. YOY change in GHG emissions (all Scopes)
Weaker than the -6.5% weighted average for S&P 500
FY2022
How is this calculated?

Genus plc aims to achieve net zero for all Scopes by 2050


This target has not been verified as science based according to SBTi
Genus plc's actual and proj. GHG emissions (all Scopes) (Kt of CO2e)

GHG emissions and Carbon intensity

Genus plc's GHG emissions (location-based) (Kt of CO2e)
Genus plc's Carbon intensity (Tons per 1 USDm)

Genus plc's carbon footprint

Genus plc reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 30 June 2021 at 82 Kt (-5.6 /-6.4% y-o-y). Also positively, carbon intensity plunged to 114 t (-11 /-8.8% y-o-y).

Genus plc's Scope 3 emissions declined to 15 Kt (-1.5 /-9% y-o-y). The rate of decline has slowed compared to the trend since 2Q'19 (CAGR -12%).

The company is committed to achieving net zero for all Scopes by 2050, which translates into the estimated reduction of -3.3 Kt per annum over the period of FY2022 - FY2050. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...